“1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients With Moderate Alzheimer Disease”. VITAE Academia Biomédica Digital 3, no. 24 (July 17, 2025). Accessed January 30, 2026. https://sosvitae.ucv.ve/index.php/vitae/article/view/391.